-
Chemistry experts develop small crystals from nanoscale encapsulated droplets
expresspharma
May 20, 2020
The new technique involving the use of inert oils to control evaporative solvent loss can unlock the potential of accelerated new drug development.
-
Tufts CSDD Releases New Study
contractpharma
May 13, 2020
Establishes demographic benchmarks for pivotal clinical trials, showing areas of under-representation.
-
Funding for AI in drug development, clinical trials and information synthesis hits $5.2bn
europeanpharmaceuticalreview
January 09, 2020
A study has suggested that while funding for artificial intelligence in pharma was $5.2bn in 2019, overall investment is slowing.
-
Application of Novel Herbal Plant and Mushroom Extract As Source in Drug Development
Lin Zhang
November 08, 2019
The use of herbal plants and mushroom extracts/compounds as medicines has a long history in the treatment various diseases and is now globally accepted in the form of pharmaceuticals and functional foods.
-
Certara launches V8.2 of Phoenix PK/PD & simulation software for drug development
biospectrumasia
September 16, 2019
Aligned with newly issued FDA Draft Guidance, Phoenix supports electronic data, methods and results audit, traceability and communication requirements
-
Experimental Drug Development Centre (EDDC) opens in Singapore
biospectrumasia
June 28, 2019
A national platform for drug discovery and development to channel and strengthen the pipeline of high potential home-grown drug candidates by collaborating across the industry, research institutes, academia, and hospitals in Singapore
-
LEO Pharma Chooses Veeva Development Cloud to Accelerate Drug Development
pharmafocusasia
March 28, 2019
Veeva Systems today announced that LEO Pharma, an international leader in medical dermatology, has selected Veeva Development Cloud applications to help boost process end-to-end business on all product development.
-
Big Pharma’s Drug Studies Are Getting a NASA-Style Makeover
firstwordpharma
January 28, 2019
Approximately a third of drug development costs come from clinical trials, and Novartis is looking to make them faster and less expensive, reported Boomberg.
-
Big Pharma’s Drug Studies Are Getting a NASA-Style Makeover
firstwordpharma
January 28, 2019
Approximately a third of drug development costs come from clinical trials, and Novartis is looking to make them faster and less expensive, reported Boomberg.
-
Novartis and University of Oxford partner on AI-based drug development
pharmaceutical-technology
January 22, 2019
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.....